Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy

by Andrea Deichl, Andrea Deichl, Frank Edelmann, Frank Edelmann
Published 2023-05-01

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction

by Ulrich Kintscher, Frank Edelmann
Published 2023-06-01

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction

by Veronika Zach, Felix Lucas Bähr, Frank Edelmann
Published 2020-03-01

Electrical and Structural Adaption of Athlete’s Heart and the Impact on Training and Recovery Management in Professional Basketball Players: A Retrospective Observational Study

by Paul Zimmermann, Paul Zimmermann, Paul Zimmermann, Othmar Moser, Othmar Moser, Frank Edelmann, Frank Edelmann, Volker Schöffl, Volker Schöffl, Max L. Eckstein, Martin Braun
Published 2022-02-01

Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized op...

by Evgeny Belyavskiy, Artem Ovchinnikov, Alexandra Potekhina, Fail Ageev, Frank Edelmann
Published 2020-09-01

Characterization of the major reactions during conversion of lignin to carbon fiber

by Hendrik Mainka, Liane Hilfert, Sabine Busse, Frank Edelmann, Edgar Haak, Axel S. Herrmann
Published 2015-10-01

Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure

by Monika Sadlonova, Thomas Meyer, Lutz Binder, Rolf Wachter, Frank Edelmann, Christoph Herrmann-Lingen
Published 2020-10-01

A Random Shuffle Method to Expand a Narrow Dataset and Overcome the Associated Challenges in a Clinical Study: A Heart Failure Cohort Example

by Lorenzo Fassina, Alessandro Faragli, Alessandro Faragli, Alessandro Faragli, Alessandro Faragli, Francesco Paolo Lo Muzio, Francesco Paolo Lo Muzio, Sebastian Kelle, Sebastian Kelle, Sebastian Kelle, Sebastian Kelle, Carlo Campana, Burkert Pieske, Burkert Pieske, Burkert Pieske, Burkert Pieske, Frank Edelmann, Frank Edelmann, Frank Edelmann, Alessio Alogna, Alessio Alogna, Alessio Alogna
Published 2020-11-01

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan

by Burkert Pieske, Daniel Messroghli, Frank Edelmann, Konrad Neumann, Annachiara Benini, Anne Bingel, Felix Schönrath
Published 2022-12-01

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-D...

by Marieke R. Wilke, Daniel Broschmann, Anja Sandek, Rolf Wachter, Frank Edelmann, Christoph Herrmann-Lingen
Published 2023-04-01

Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study

by Anna Schertz, Birgit Herbeck Belnap, Mira‐Lynn Chavanon, Frank Edelmann, Rolf Wachter, Christoph Herrmann‐Lingen
Published 2019-08-01

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study

by Abass Eidizadeh, Moritz Schnelle, Andreas Leha, Frank Edelmann, Kathleen Nolte, Stefanie Maria Werhahn, Lutz Binder, Rolf Wachter
Published 2023-02-01

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observatio...

by Thomas Meyer, Mira-Lynn Chavanon, Christoph Herrrmann-Lingen, Maren Roggenthien, Kathleen Nolte, Burkert Pieske, Rolf Wachter, Frank Edelmann
Published 2015-01-01

NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome

by Petra Gehle, Peter N. Robinson, Frank Heinzel, Frank Edelmann, Mustafa Yigitbasi, Felix Berger, Volkmar Falk, Burkert Pieske, Ernst Wellnhofer
Published 2016-09-01

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction

by Judith Fitz, Frank Edelmann, Gerd Hasenfuß, Anja Sandek, Kathleen Nolte, Djawid Hashemi, Tobias D. Trippel, Rolf Wachter, Christoph Herrmann‐Lingen
Published 2021-12-01

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trialsResearch...

by Karl-Patrik Kresoja, Matthias Unterhuber, Rolf Wachter, Karl-Philipp Rommel, Christian Besler, Sanjiv Shah, Holger Thiele, Frank Edelmann, Philipp Lurz
Published 2023-10-01

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

by Djawid Hashemi, Ludwig Dettmann, Tobias D. Trippel, Volker Holzendorf, Johannes Petutschnigg, Rolf Wachter, Gerd Hasenfuß, Burkert Pieske, Antonia Zapf, Frank Edelmann
Published 2020-06-01

De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients

by Matthias Bock, Clemens von Schacky, Johannes Scherr, Elke Lorenz, Benjamin Lechner, Alexander Krannich, Rolf Wachter, André Duvinage, Frank Edelmann, Katharina Lechner
Published 2023-07-01

An altered plasma lipidome–phenome network characterizes heart failure with preserved ejection fraction

by Nina Jovanovic, Anna Foryst‐Ludwig, Christian Klose, Cristina Rozados daConceicao, Lina Alasfar, Till Birkner, Sofia K. Forslund, Ulrich Kintscher, Frank Edelmann
Published 2024-06-01

Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR

by Djawid Hashemi, Djawid Hashemi, Djawid Hashemi, Patrick Doeblin, Patrick Doeblin, Moritz Blum, Karl Jakob Weiss, Karl Jakob Weiss, Matthias Schneider, Matthias Schneider, Rebecca Beyer, Rebecca Beyer, Burkert Pieske, Burkert Pieske, Burkert Pieske, Hans-Dirk Duengen, Hans-Dirk Duengen, Frank Edelmann, Frank Edelmann, Sebastian Kelle, Sebastian Kelle, Sebastian Kelle
Published 2023-02-01